Literature DB >> 6924825

Synergism between vancomycin and gentamicin or tobramycin for methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains.

C Watanakunakorn, J C Tisone.   

Abstract

By the time-kill curve method, the combinations of vancomycin-gentamicin and vancomycin-tobramycin were shown to be synergistic against a majority of methicillin-susceptible and -resistant strains of Staphylococcus aureus.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6924825      PMCID： PMC185681          DOI： 10.1128/AAC.22.5.903

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  9 in total

1.  Antibiotic-tolerant Staphylococcus aureus.

Authors:  C Watanakunakorn
Journal:  J Antimicrob Chemother       Date:  1978-11       Impact factor: 5.790

2.  Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin.

Authors:  R J Faville; D E Zaske; E L Kaplan; K Crossley; L D Sabath; P G Quie
Journal:  JAMA       Date:  1978-10-27       Impact factor: 56.272

3.  Antistaphylococcal activity of rifampin with other antibiotics.

Authors:  S H Zinner; H Lagast; J Klastersky
Journal:  J Infect Dis       Date:  1981-10       Impact factor: 5.226

4.  Interaction between vancomycin and rifampin against Staphylococcus aureus.

Authors:  C Watanakunakorn; J C Guerriero
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

5.  Enhancement of the effects of anti-staphylococcal antibiotics by aminoglycosides.

Authors:  C Watanakunakorm; C Glotzbecker
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

6.  Treatment of infections due to methicillin-resistant Staphylococcus aureus.

Authors:  C Watanakunakorn
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

7.  In vitro activity of rifampin alone and in combination with nafcillin and Vancomycin against pathogenic strains of Staphylococcus aureus.

Authors:  C U Tuazon; M Y Lin; J N Sheagren
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

8.  The antibacterial action of vancomycin.

Authors:  C Watanakunakorn
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec

9.  The efficacy of rifampin as adjunctive therapy in selected cases of staphylococcal endocarditis.

Authors:  R M Massanari; S T Donta
Journal:  Chest       Date:  1978-03       Impact factor: 9.410
  9 in total
  24 in total

1.  Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faecium.

Authors:  R C Mercier; H H Houlihan; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

Review 2.  Methicillin-resistant staphylococci: detection methods and treatment of infections.

Authors:  C J Hackbarth; H F Chambers
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

3.  Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.

Authors:  H H Houlihan; R C Mercier; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

Review 4.  Methicillin-resistant staphylococci.

Authors:  H F Chambers
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

5.  Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections.

Authors:  Pamela A Moise-Broder; Alan Forrest; Mary C Birmingham; Jerome J Schentag
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

6.  Clinical experience of cefotaxime in infections caused by gram-positive pathogens.

Authors:  D Bassetti; M Solbiati; G Fraizzoli
Journal:  Infection       Date:  1985       Impact factor: 3.553

7.  In vitro susceptibilities of four species of coagulase-negative staphylococci.

Authors:  R J Fass; V L Helsel; J Barnishan; L W Ayers
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

8.  Efficacies of vancomycin, arbekacin, and gentamicin alone or in combination against methicillin-resistant Staphylococcus aureus in an in vitro infective endocarditis model.

Authors:  Dong-Gun Lee; Hye-Sun Chun; Dong-Seok Yim; Su-Mi Choi; Jung-Hyun Choi; Jin-Hong Yoo; Wan-Shik Shin; Moon-Won Kang
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

9.  Biofilm Antimicrobial Susceptibility Increases With Antimicrobial Exposure Time.

Authors:  Paulo Castaneda; Alex McLaren; Gamuchirai Tavaziva; Derek Overstreet
Journal:  Clin Orthop Relat Res       Date:  2016-07       Impact factor: 4.176

Review 10.  Rationale for one stage exchange of infected hip replacement using uncemented implants and antibiotic impregnated bone graft.

Authors:  Heinz Winkler
Journal:  Int J Med Sci       Date:  2009-09-04       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.